Velentza L, Wickstrom M, Kogner P, Ohlsson C, Zaman F, Savendahl L
Sci Rep. 2023; 13(1):8054.
PMID: 37198212
PMC: 10192431.
DOI: 10.1038/s41598-023-34965-4.
Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D
Cell Death Differ. 2023; 30(5):1097-1154.
PMID: 37100955
PMC: 10130819.
DOI: 10.1038/s41418-023-01153-w.
Ke F, Holloway S, Uren R, Wong A, Little M, Kluck R
EMBO J. 2022; 41(15):e110300.
PMID: 35758142
PMC: 9340487.
DOI: 10.15252/embj.2021110300.
Dinh K, Wang Q
Biophys J. 2022; 121(13):2638-2652.
PMID: 35714600
PMC: 9300639.
DOI: 10.1016/j.bpj.2022.05.035.
Brinkmann K, Ng A, de Graaf C, Strasser A
Cell Death Differ. 2022; 29(6):1079-1093.
PMID: 35388168
PMC: 9177562.
DOI: 10.1038/s41418-022-00987-0.
Immune Dysregulation in Patients With Chromosome 18q Deletions-Searching for Putative Loci for Autoimmunity and Immunodeficiency.
Hogendorf A, Zielinski M, Constantinou M, Smigiel R, Wierzba J, Wyka K
Front Immunol. 2021; 12:742834.
PMID: 34867966
PMC: 8637865.
DOI: 10.3389/fimmu.2021.742834.
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs.
Diepstraten S, Anderson M, Czabotar P, Lessene G, Strasser A, Kelly G
Nat Rev Cancer. 2021; 22(1):45-64.
PMID: 34663943
DOI: 10.1038/s41568-021-00407-4.
The anti-apoptotic Bcl-2 protein regulates hair follicle stem cell function.
Geueke A, Mantellato G, Kuester F, Schettina P, Nelles M, Seeger J
EMBO Rep. 2021; 22(10):e52301.
PMID: 34342114
PMC: 8490995.
DOI: 10.15252/embr.202052301.
HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways.
Miyamoto R, Kanai A, Okuda H, Komata Y, Takahashi S, Matsui H
Elife. 2021; 10.
PMID: 34310280
PMC: 8313233.
DOI: 10.7554/eLife.64148.
Requirement for antiapoptotic MCL-1 during early erythropoiesis.
Turnis M, Kaminska E, Smith K, Kartchner B, Vogel P, Laxton J
Blood. 2021; 137(14):1945-1958.
PMID: 33512417
PMC: 8033457.
DOI: 10.1182/blood.2020006916.
BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells.
Loo L, Soetedjo A, Lau H, Ng N, Ghosh S, Nguyen L
Cell Death Dis. 2020; 11(5):378.
PMID: 32424151
PMC: 7235254.
DOI: 10.1038/s41419-020-2589-7.
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance.
Park E, Chen J, Moore A, Mangolini M, Santoro A, Boyd J
Sci Transl Med. 2020; 12(526).
PMID: 31941829
PMC: 7116365.
DOI: 10.1126/scitranslmed.aax9340.
Apoptosis and autophagy in polycystic kidney disease (PKD).
Nowak K, Edelstein C
Cell Signal. 2019; 68:109518.
PMID: 31881325
PMC: 7127985.
DOI: 10.1016/j.cellsig.2019.109518.
Anti-apoptotic BCL-2 family members in development.
Opferman J, Kothari A
Cell Death Differ. 2017; 25(1):37-45.
PMID: 29099482
PMC: 5729530.
DOI: 10.1038/cdd.2017.170.
gene dosage is critical in modulating nephron progenitor survival in the absence of microRNAs during kidney development.
Cerqueira D, Bodnar A, Phua Y, Freer R, Hemker S, Walensky L
FASEB J. 2017; 31(8):3540-3554.
PMID: 28446592
PMC: 5503708.
DOI: 10.1096/fj.201700010R.
Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.
Schenk R, Tuzlak S, Carrington E, Zhan Y, Heinzel S, Teh C
Cell Death Differ. 2017; 24(3):534-545.
PMID: 28085150
PMC: 5344213.
DOI: 10.1038/cdd.2016.156.
Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells.
Shinde V, Srinivasan S, Henry M, Rotshteyn T, Hescheler J, Rahnenfuhrer J
Stem Cell Res Ther. 2017; 7(1):190.
PMID: 28038682
PMC: 5203708.
DOI: 10.1186/s13287-016-0449-2.
Bcl-2 is a critical mediator of intestinal transformation.
van der Heijden M, Zimberlin C, Nicholson A, Colak S, Kemp R, Meijer S
Nat Commun. 2016; 7:10916.
PMID: 26956214
PMC: 4786877.
DOI: 10.1038/ncomms10916.
The tissue dependent interactions between p53 and Bcl-2 in vivo.
Li X, Miao X, Wang H, Xu Z, Li B
Oncotarget. 2015; 6(34):35699-709.
PMID: 26452131
PMC: 4742135.
DOI: 10.18632/oncotarget.5372.
Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.
Opferman J
FEBS J. 2015; 283(14):2661-75.
PMID: 26293580
PMC: 4761532.
DOI: 10.1111/febs.13472.